期刊文献+

脑钠肽在息性冠脉综合征中临床研究

Clinical research of plasma brain natriuretic- peptlde in acute coronary syndrome
下载PDF
导出
摘要 目的:研充血浆脑钠肽(BNP)水平与严重程度不同的急性冠脉综合征(ACS)的联系.方法:采用免疫荧光法检测200例ACS患者起病24h内血浆BNP水平,其中不稳定心搜痛(UA)72例、非ST抬高性心肌梗死(NSTEMD58例、ST抬南性心肌梗死(STEMI)70例,对照组(CONTROL):72例,健康中、老年人。研充BNP水平与不同ACS的联系。结果:CoNTROL组、UA组、NSTEMI组、STEMI组血浆BNP水平分别是62.86±6.72、143.06±12.87、279.42±28.81、617.54±69.56pg/ml,各组间比较具有显著差异(P〈0.05).结论;血浆BNP水平变化与冠状动脉病变的严重程度相关,可作为ACS病情严重与否的评价标准. Objective To research the relation between plasma brain natriuretic peptide (BNP) level and various kinds of acute coronary syndrome (ACS). Methods Two hundred ACS patients were enrolled to detect plasma BNP level by immumofluorescence method within 24 hours after the onset, including 72 unstable angina pectoris (UA), 58 non ST segment elevation myocardial infarction (NSTEMI) and 70 ST segment elevation myocardial infarc- tion (STEMI) cases, CONTROL, ?2 health mlddle--aged and aged people. The relation between BNP level and various kinds of ACS was analyzed. Re- sults Plasma level of BNP in CONTROL, UA, NSTEMI and STEMI groups was 62.86±6.72, 143.06±12.87, 279.42±28.81, 617.54:1:69.56pg/ml. There was a significant difference among all groups (P〈0.05). Conclusion: The elevation of plasma BNP level is correlated with the severity of coronary artery lesion and could evaluate the ACS patients condition.
出处 《医学信息(下旬刊)》 2011年第7期25-25,共1页 Medical information
关键词 脑钠肤 急性冠脉综合征 临床研究 brain natriuretic peptide acute coronary syndrome clinical research
  • 相关文献

参考文献10

  • 1石林,李俊成,秦晓群.临床生理学[M].北京:科学出版社,2001.187-188.
  • 2Jin Y,Zhong YM,Yang XL,et al.Natriuretic peptides are localized to rat retinal amacrine ce11s[J].Neurosci Lett,2007,421(2):106-109.
  • 3Kwan G,Isakson SR,Beede J,et a1.Short-term serial sampling of natriuretic peptides in patients presenting with chest pain[J].J Am Coll Cardiol,2007,49(11):1186-1192.
  • 4Suzuki S,Yoshimura M,Nakayama M,et al.Plasma level of B-type natriuretic peptide as aprognostic marker after acute myocardial infarction:a long-termfollow-up analysis[J].Circulation,2004,110(11):1387-1391.
  • 5赵思勤,李秋,吴涛,刘小蓉,赵宁,聂晓莉,王勉,胡咏梅.心力衰竭患者脑利钠肽浓度与血流动力学的关系及临床意义[J].中华心血管病杂志,2005,33(6):502-504. 被引量:40
  • 6Bassan R,Potsch A,Maisel A,et al.B type natriuretic peptide:a nove learly blood marker of acute myocardial infarction in patients with chest pain and no ST segment elevation[J].Eur Heart,2005,26(3):234-240.
  • 7Arakawa N,Nakamura M,Aoki H,Hiramoui K,et al.Relationship between plasma level of brain natriuretic peptide and myocardial infarct size.Cardiology,1994,85:334-40.
  • 8Sabatine MS,Morrow DA,de Lemos JA,et al.Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes:simultaneous assessment of troponin I C-reactive protein,and B-type natriuretic peptide.Circrlation,2002,105:1760-1763.
  • 9Galvani M,Ferrini D,Ottani F.Natriuretic peptides for risk stratification of patients with acute coronary syndromes[J].Eur J Heart Fail,2004,6(3):327-333.
  • 10张政.脑钠肽与心血管疾病[J].中国临床实用医学,2009,3(9):125-126. 被引量:1

二级参考文献8

  • 1Yoshimura M, Yasue H, Okamura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993,87:464-469.
  • 2Dickstein K. Natriuretic peptides in detection of heart failure. Lancet, 1997,351:3-4.
  • 3Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol, 1998,274:H1684-H1689.
  • 4Maeda K, Takayoshi T, Wada T, et al. Palsma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998,135:825-832.
  • 5Clerio A, Lervasi G, Chicca M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 1998,21:170-179.
  • 6Maisel A. B-type natriuretic peptide levels: a potential novel "hite count" for congestive heart failure. J Cardiac Fail, 2001,7:183-193.
  • 7Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.J Am Coll Cardiol,2002,39:202-209.
  • 8赵丽,吴学思,韩智红,胡荣,吕强.B型利钠肽检测对心力衰竭患者的临床评估[J].中华心血管病杂志,2004,32(1):51-52. 被引量:164

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部